Eric Tse: Became a billionaire overnight, U30 like a 18-year-old, a series of "pink balls" surrounded

Thanks to a "huge gift" from his parents, Eric Tse became a billionaire overnight, surprising the public. Currently, he is not only rich but also powerful when he holds the position of CEO of a trillion-dollar pharmaceutical group.

In the context of China's economy witnessing remarkable development, the names of talented young entrepreneurs, especially those who inherit large corporations, always attract the attention of the public. Among them, Eric Tse (born in 1995) emerged as a typical face, dubbed the "legend" of the young billionaire by the media and the public.

Solid academic background and social media image

Eric Tse was born in Seattle, USA, but has Chinese nationality. After completing his high school program, he went to the United States to study finance at the Wharton School, of the University of Pennsylvania, one of the world's most prestigious business schools.

In his first academic year, Eric Tse planned the Penn Wharton China conference with the participation of the country's leading business leaders of billions of people and 1,500 students from 85 countries.

After that, the rich "warm boy" continued to improve his education by studying for a Master's degree in Global Management and Leadership at Schwarzman Academy, Tsinghua University.

Besides his academic life, Eric Tse was also a prominent figure on the social network Instagram in the early stages. He regularly posts personal photos, showing a diverse life with many activities such as meeting celebrities, traveling to many places around the world, and everyday moments with relatives.

Through these activities, Eric Tse has built an image of a young, talented, educated person with a dashing and youthful appearance, attracting attention from a large number of people.

Many people expressed surprise when they learned Eric Tse's real age and praised him for looking younger than his age. Regarding his personal life, especially his love affair, Eric still keeps information private, making this an unknown to the public.

The turning point to become a billionaire and attention from the media

Eric Tse first made headlines in the global media in 2019. At that time, he suddenly joined the ranks of the richest people in the world overnight, thanks to receiving an inheritance "gift" worth $3.8 billion (equivalent to about 95 trillion VND) from his father - Mr. Ping Tse. This asset corresponds to 45% of the shares of Sino Biopharmaceutical Pharmaceutical Group.

This event "rich young master inherits wealth" quickly climbed to the top of search topics on social networks in the country of billions of people. Information about Eric Tse also began to be widely searched, making him the focus of public opinion.

However, when answering the media about this issue, Eric Tse did not share details about the wealth he received. Instead, he aims to focus on the goal of becoming a true entrepreneur in the future, showing the seriousness and vision of a young successor.

Operating role and size of Sino Biopharmaceutical Group

Currently, Eric Tse has focused on sharing more about his work through his personal Weibo page. He is currently holding the position of CEO of Sino Biopharmaceutical Group. In addition, Eric Tse serves as Chairman of Chia Tai Tianqing Pharmaceutical Group, the largest and most important subsidiary of Sino Biopharmaceutical, specializing in the treatment of cancer, liver and respiratory diseases.

It is known that in addition to the position of CEO of Sino Biopharmaceutical, Eric Tse also leads 5 other CTs in Hong Kong. Young and talented and with an outstanding family, the billionaire often meets celebrities and is surrounded by many pink shadows. But for now, his love story is kept private, not yet publicizing his girlfriend.

According to Chinese media and the group's official website, Sino Biopharmaceutical Limited (Sino Biopharm) is known as the "giant" of the Asian pharmaceutical industry and one of the largest and most influential pharmaceutical corporations in China.

As of 2025, Sino Biopharmaceutical Group owns a significant scale of operations with more than 25,000 employees nationwide. The group's annual revenue has exceeded 30 billion yuan (about 106 trillion VND).

Not only that, Sino Biopharmaceutical also has more than 20 subsidiaries and member units, affiliated enterprises, with headquarters and many strategic production facilities in major cities of China such as Beijing, Shanghai, Nanjing, Lianyungang, Qingdao and many other locations.

Among them, Chia Tai Tianqing Pharmaceutical stands out as one of the key units, focusing specifically on the development of drugs for the treatment of cancer and liver disease, two areas of great significance for public health in China.

Eric Tse's family legacy and status

Information about Eric Tse's specific personal assets was not disclosed in detail. However, according to Forbes' ranking, as of May 2025, the estimated total wealth of Mr. Tse's family – including Ping Tse (founder of Sino Biopharmaceuticals), son Eric Tse and daughter Theresa Tse (Chairman of Sino Biopharmaceuticals) – reaches about $5.3 billion. With this wealth, they are ranked 693 on the list of global billionaires.

Eric Tse is currently the largest individual shareholder of Sino Biopharmaceutical. The role of CEO of the group he has been in since 2022, ushering in an important step in the executive career of a young person in the competitive pharmaceutical industry. Eric's holding this important position at such a young age demonstrates the trust of his family and board of directors in his ability and vision to lead the group to continue to grow.

The context of the pharmaceutical industry and the vision of the next generation

Eric Tse's rise is part of a growing trend of young heirs in China gradually taking over family business empires. In the context of China's pharmaceutical industry is growing strongly and has high requirements for innovation and technology, the holding of a young CEO like Eric in a leadership position brings both challenges and opportunities.

This new generation of leaders is often expected to bring a modern mindset, the ability to adapt quickly to technology and the market, and maintain the core values of the family business. Eric Tse's role is not only to manage a large corporation, but also to exemplify the generational shift in China's billion-dollar enterprises.